Skip to content

To Know Which supportive management of acute bronchiolitis is better in efficacy among 7% saline and 3% saline used in nebulization.

Efficacy of 7% Vs 3% Saline Nebulization in Acute Bronchiolitis - A Randomised Control Trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067292
Enrollment
130
Registered
2024-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J210- Acute bronchiolitis due to respiratory syncytial virus Health Condition 2: J00-J06- Acute upper respiratory infections

Interventions

Intervention1: Saline Nebulisation: Dose - 4ml - 7% Normal Saline Route of administration- Nebulisation with face mask via Sterile Nebuliser Machine. Duration - 20 mins or till the nebuliser chamber

Sponsors

Aarupadai Veedu Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Hospitalized Infants and young children(6 to 24 months) 2.First episode of respiratory distress associated with wheezing 3.Clinical severity score 0 to 6 (ANNEXURE-1)

Exclusion criteria

Exclusion criteria: 1.History of two or more episodes of respiratory distress in past 2.H/o Pneumonia & Antibiotic use 3.Family history of asthma 4.Critically ill Infants and young children (6 to 24 months) suggesting severe acute bronchiolitis 5.Associated cardiopulmonary diseases such as congenital heart disease, cystic lung disease, etc. 6.Preterm birth or history of mechanical ventilation in neonatal period 7.Patients with clinical signs of bacterial infection

Design outcomes

Primary

MeasureTime frame
Nebulisation with 7% saline has better efficacy than 3% saline in supportive management of acute bronchiolitis.Timepoint: Clinical Severity Score is Calculated every 24 hours till the day of the discharge.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Thumjaa A

Aarupadai Veedu Medical College and Hospital

thumjaa.annamalai@avmc.edu.in9841573725

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026